Download full-text PDF

Source
http://dx.doi.org/10.4161/cc.8.15.9206DOI Listing

Publication Analysis

Top Keywords

human-in-mouse breast
4
breast cancer
4
cancer model
4
human-in-mouse
1
cancer
1
model
1

Similar Publications

State of the Art Modelling of the Breast Cancer Metastatic Microenvironment: Where Are We?

J Mammary Gland Biol Neoplasia

July 2024

Breast Biology Group, Manchester Breast Centre, Division of Cancer Sciences, Oglesby Cancer Research Building, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, M20 4GJ, UK.

Metastatic spread of tumour cells to tissues and organs around the body is the most frequent cause of death from breast cancer. This has been modelled mainly using mouse models such as syngeneic mammary cancer or human in mouse xenograft models. These have limitations for modelling human disease progression and cannot easily be used for investigation of drug resistance and novel therapy screening.

View Article and Find Full Text PDF

TopPICR: A Companion R Package for Top-Down Proteomics Data Analysis.

J Proteome Res

February 2023

Biological Sciences Division, Pacific Northwest National Laboratory, Richland, Washington99352, United States.

Top-down proteomics is the analysis of proteins in their intact form without proteolysis, thus preserving valuable information about post-translational modifications, isoforms, and proteolytic processing. However, it is still a developing field due to limitations in the instrumentation, difficulties with the interpretation of complex mass spectra, and a lack of well-established quantification approaches. TopPIC is one of the popular tools for proteoform identification.

View Article and Find Full Text PDF

Deep Learning Enables Individual Xenograft Cell Classification in Histological Images by Analysis of Contextual Features.

J Mammary Gland Biol Neoplasia

June 2021

Biomedical Imaging Group, School of Engineering, Ecole Polytechnique Fédéralé de Lausanne (EPFL), Lausanne, Switzerland.

Patient-Derived Xenografts (PDXs) are the preclinical models which best recapitulate inter- and intra-patient complexity of human breast malignancies, and are also emerging as useful tools to study the normal breast epithelium. However, data analysis generated with such models is often confounded by the presence of host cells and can give rise to data misinterpretation. For instance, it is important to discriminate between xenografted and host cells in histological sections prior to performing immunostainings.

View Article and Find Full Text PDF

Clinical proteomics requires large-scale analysis of human specimens to achieve statistical significance. We evaluated the long-term reproducibility of an iTRAQ (isobaric tags for relative and absolute quantification)-based quantitative proteomics strategy using one channel for reference across all samples in different iTRAQ sets. A total of 148 liquid chromatography tandem mass spectrometric (LC-MS/MS) analyses were completed, generating six 2D LC-MS/MS data sets for human-in-mouse breast cancer xenograft tissues representative of basal and luminal subtypes.

View Article and Find Full Text PDF

In the present work, the potential of trapped ion mobility spectrometry coupled to TOF mass spectrometry (TIMS-TOF MS) for discovery and targeted monitoring of peptide biomarkers from human-in-mouse xenograft tumor tissue was evaluated. In particular, a TIMS-MS workflow was developed for the detection and quantification of peptide biomarkers using internal heavy analogs, taking advantage of the high mobility resolution (R = 150-250) prior to mass analysis. Five peptide biomarkers were separated, identified, and quantified using offline nanoESI-TIMS-CID-TOF MS; the results were in good agreement with measurements using a traditional LC-ESI-MS/MS proteomics workflow.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!